The Immunobiological Mechanisms of Depression in Perimenopause

Recruiting Observational Study
Perimenopause Major Depressive Episode (MDE)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 55
Sex
Female
Study type
Observational
Participants needed
120 (estimated)
Sponsor
Van Andel Research Institute · Other
Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This project aims to identify immunobiological mechanisms underlying the development of depression during the perimenopause. During the perimenopause, the risk for recurrence of depression is increased 13-fold among women who previously had depression. Moreover, perimenopause overlaps with the age span exhibiting the highest suicide rate for women. The perimenopause can last for several years and …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * • Biological women, age 40 to 55. * Undergoing perimenopause according to STRAW criteria \[1\]. * All races and national origins can be included. * English speaking (since all clinical rating scales to be used here have not been developed and validated for non-English s…
Contacts

Lena Cecilia Brundin, MD, PhD

616-234-5379

lena.brundin@vai.org

CONTACT

Qiong Sha, PhD

616-234-5498

jade.sha@vai.org

CONTACT